- M&A Activity
L3 Technologies (NYSE: LLL), then L-3 Communications, has wrapped up its purchase of Implant Sciences explosive trace detection business for $117.5 million cash through an asset purchase agreement. Michael Strianese, chairman and CEO of L3, said in a statement released Thursday the acquisition will help expand L3s presence in nation...


